Dare Bioscience (DARE) EV to FCF (2017 - 2025)
Dare Bioscience's (DARE) quarterly EV to FCF came in at 2.56 in Q4 2025, down 221.13% on a YoY basis from 2.12 in Q4 2024, and up 72.92% quarter-over-quarter from 9.47 in Q3 2025.
Powered by 
Analysis
Dare Bioscience (DARE) EV to FCF (2017 - 2025) Analysis & Trends
Dare Bioscience (DARE) has reported EV to FCF for 9 consecutive years, with 2.56 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, EV to FCF fell 221.13% year-over-year to 2.56; the trailing twelve-month figure through Dec 2025 stood at 0.3 (down 86.95% YoY), and the FY2025 full-year result was 0.3, down 86.95% from the prior year.
- EV to FCF advanced to 2.56 in Q4 2025 per DARE's latest filing, from 9.47 in the prior quarter.
- Across five years, EV to FCF topped out at 63.06 in Q3 2021 and bottomed at 10.14 in Q2 2023.
- Historically, EV to FCF has averaged 1.11 across 5 years, with a median of 4.12 in 2023.
- The sharpest annual moves came in 2021 and 2025: EV to FCF jumped 1299.32% in 2021, then plunged 316.17% in 2025.
- Over 5 years, EV to FCF stood at 7.15 in 2021, then rose by 15.27% to 6.06 in 2022, then surged by 61.63% to 2.32 in 2023, then surged by 191.06% to 2.12 in 2024, then sank by 221.13% to 2.56 in 2025.
- According to Business Quant data, EV to FCF over the past three periods registered 2.56, 9.47, and 3.18 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Dare Bioscience | 10.92 Mn | -1.70 Mn | -132,343.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -2.56 |
| Sep 30, 2025 | -9.47 |
| Jun 30, 2025 | -3.18 |
| Mar 31, 2025 | -2.70 |
| Dec 31, 2024 | 2.12 |
| Sep 30, 2024 | -2.61 |
| Jun 30, 2024 | 1.47 |
| Mar 31, 2024 | -7.06 |
| Dec 31, 2023 | -2.32 |
| Sep 30, 2023 | -3.96 |
| Jun 30, 2023 | -10.14 |
| Mar 31, 2023 | -4.29 |
| Dec 31, 2022 | -6.06 |
| Sep 30, 2022 | 5.16 |
| Jun 30, 2022 | -8.43 |
| Mar 31, 2022 | -7.00 |
| Dec 31, 2021 | -7.15 |
| Sep 30, 2021 | 63.06 |
| Jun 30, 2021 | -8.43 |
| Mar 31, 2021 | -8.63 |